UNLABELLEDFlapless implant placement requires punch removal of the gingiva without flap reflection, suggesting this technique will be less invasive, and with less tissue destruction, than comparable alternative techniques.METHODSEleven implants were placed with flapless (FL) technique and 11 implants were placed with full-thickness flap (FT) technique in split mouth technique. FL technique was done with dermal tissue puncture, while FT was performed with crestal incision, including the papillae. Patients were followed-up postoperatively for clinical and morbidity evaluation in both groups.RESULTSThere was no pain, and there were only mild signs of inflammation, at the sites of flapless implant placement in the 11 patients studied. In contrast, there were complaints of mild to moderate pain and signs of inflammation at the site of full-thickness flap implant placement in the 11 patients studied. In addition, there was gingival overgrowth over the healing cap noted in this group.CONCLUSIONSFL technique may be recommended for the apprehensive or hyperalgesic patient because of the absence of pain it conveys, as well as the decreased postoperative swelling. Periosteal disruption is responsible for the patient's morbidity postoperatively.
UNLABELLED:There is evidence suggesting that flapless, or minimally invasive, procedures can preserve bone vascularization because they will not disturb the periosteum of the alveolar bone. The aim of this randomized, controlled clinical trial study is to compare the effect of flapless (FL) and full-thickness flap (FT) techniques on crestal bone resorption during healing periods.METHODS:Twenty-two implants were placed by FL and FT flap in nine patients in split mouth design; each patient received two implants, except for two patients who received four implants. A periapical radiograph was taken at implant placement, as well as 6- and 12-week intervals. Crestal bone level was compared between FL and FT during these intervals and compared between intervals for each group.RESULTS:Median (IQR) crestal bone level at implant placement for the FL was 2.70 (0.60) and for the FT was 2.60 (1.20). At six weeks, median (IQR) for the FL was 3.55 (0.70) and for the FT was 3.40 (0.75). At 12 weeks, median (IQR) for the FL was 3.60 (0.30) and for the FT was 3.75 (0.85). Statistically insignificant differences were obtained between the two techniques at implant placement, as well as 6- and 12-week intervals, and were p = 0.894, p = 0.477, p = 0.755, respectively. There was a significant difference between the bone level at implant placement and at the 6-week interval for both the FL (p = 0.006) and FT (p = 0.045), whereas there was no significant difference between the bone level at 6- and 12-week intervals for the FL (p = 0.722) and for the FT (p = 0.229). Conclusions Based upon this study of nine patients with 22 implants, there was no significant difference in crestal bone resorption between FT and FL techniques during a three-month healing period. The preservation of periosteum in the FL group resulted in early progressive bone resorption.
The purpose of this study is to evaluate the effect of platelet-rich plasma (PRP) on the osseointegration of dental implants in diabetic patients. A split-mouth design was employed in all 14 patients, with each patient receiving two mini implants. A PRP-coated mini implant was installed in one quadrant as a trial and a plain mini implant was added in the opposite quadrant to serve as a control. Radiographic evaluation was done at 3, 6, and 9 weeks after implant placement. Radiographic density is measured at five points around the implants, repeatedly. Results showed no statistically significant difference between the two groups of implants. The minimally invasive mini implants successfully maintained integration at the end of 9 weeks. There were no cases of implant failure. The results of this study suggest that platelet-rich plasma implant coating has no significant effect in reducing the time for mini implant osseointegration in diabetic patients.
